MediciNova, Inc.
METHODS OF TREATING OPHTHALMIC DISEASE/DISORDER OR INJURY WITH IBUDILAST

Last updated:

Abstract:

This disclosure is directed to methods of treating ophthalmic disease/disorder or injury associated with neurodegenerative disease/disorder, such as progressive multiple sclerosis, or a neuro-ophthalmologic disorder in human patients using ibudilast.

Status:
Application
Type:

Utility

Filling date:

18 Oct 2019

Issue date:

23 Apr 2020